Home > Boards > US OTC > Medical - Healthcare >

Itonis Inc. (ITNS)

ITNS RSS Feed
Add ITNS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator sunspotter, keithkeith2112, dcsteve, Fishercat, Mechanic71, LDVolume
Search This Board:
Last Post: 7/31/2014 8:54:31 PM - Followers: 383 - Board type: Free - Posts Today: 24

                      

Itonis Holdings



 

OTC Pink Current Information

 

Market Value
$2,470,928  a/o Mar 05, 2014


Shares Outstanding
852,044,186  a/o Aug 31, 2013

Float
154,828,864 a/o May 31, 2013
 

Authorized Shares
1,000,000,000  a/o Aug 31, 2013

http://itonisholdings.com/

and

http://paramountdiscoveries.com/

 

 

 

 

   
1. devision


ABOUT ITONIS PHARMACEUTICALS

Itonis pharmaceuticals was created as a new division of Itonis, Inc. in collaboration with world-famous Dr. Charles Hensley, the inventor of the Zicam® Cold Remedy. This innovative pharmaceutical organization will produce and market prescription homeopathic preparations and over-the-counter products to treat chronic diseases and common ailments. The company will select products based on the speed to market seeking to bypass where appropriate the traditional and lengthy FDA approval process, while still maintaining the strictest levels of both safety and efficacy.

Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of Geltech, LLC, the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.



PIPELINE

 

In late August of 2012, Itonis pharmaceuticals introduced an over-the-counter, systemically active preparation delivered via a nasal and/or sublingual spray for the alleviation of mild to moderate nausea caused by motion sickness, dizziness, migraine, gastroenteritis, food poisoning, and possibly by chemotherapy, without many of the common side effects associated with current OTC and prescription treatments.

While the actual size of the market for nausea related drugs and preparations is difficult to estimate, it is suggested to be over half a billion dollars annually.
Itonis Pharmaceuticals plans to announce the details of upcoming human clinical studies for the nausea preparation formulation over the coming weeks as it files its provisional patents to protect its intellectual property.
 

http://itonisholdings.com/wp-content/uploads/2013/05/Emesyl2-4.jpg


MANAGEMENT TEAM

  • Charles Hensley, Ph.D

Charles Hensley, Ph.D., the inventor of Zicam® cold remedy is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic cocktails. In 1997, Dr. Hensley founded Geltech, LLC., the company that launched Zicam® and made the product a household name. With the launch of of Zicam® cold remedy, Dr. Hensley and co-workers changed the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley also developed Zicam® Allergy and the nasal delivery systems used in the Zicam® product line extensions. Dr. Hensley and his partners sold their stake in Geltech to Matrixx initiatives (MTXX).

In 2000, Dr. Hensley was president of Zengen, Inc., a bio-pharmaceutical company, and 2003 founded and served as Chairman and CEO of PRB Pharmaceuticals. He recently co-founded Universal Bio Innovations.

He received his B.S. from the University of Oklahoma and his Ph.D. in Physiology and Biophysics from the University of Southern California. He completed his post-doctoral fellowship in Molecular Cardiology at The University of Southern California in 1993. Subsequently he taught at The University of Southern California School of Pharmacy and medical students at the University of California, Riverside.

  • Mark Cheung

Mr. Cheung has more than 20 years of business law and entrepreneurial experience in the legal fields of business litigation and appeals. He has been a name partner at his Irvine, California law firm that has handled numerous business litigation and intellectual property matters, including a trademark case that ended favorably in the U.S. Supreme Court. Through years of litigation matters, Mr. Cheung has confronted unprecedented business operational disputes and relationship issues, providing industry opportunities to enhance and apply problem-solving skills at all levels.

Since 2001, Mr. Cheung has served on and chaired various not-for-profit boards for several organizations in Orange County, California. He chaired a consumer financial non-profit organization that included 20+ staff, over $2 million in assets and $1.7 million in annual revenues. He has chaired at a community college foundation with over $1.5 million in assets and endowments. Mr. Cheung has also served as a board member to several attorney bar associations, including the chair position for one such association.

Through his decade-long experience of serving and giving back to his community, Mr. Cheung found that such charitable organizations provided him first-hand experience with all aspects of the corporate and business world, including personnel, operations, financial, competition concerns, and reserve investing.

Since 2005, Mr. Cheung has also served as an adjunct professor, teaching upper-class levels at Chapman University School of Law.

Mr. Cheung received his Bachelor of Arts degree in Economics from Brandeis University, and his law degree from Boston College Law School. He has also published scholarly articles in the law.
 


2. devision

VERTEX

Paramount Discoveries









How Paramount Discoveries Became A Scientific Research Company


Paramount Discoveries, Inc. is a scientific research company originally founded in 1995 by Stuart Robbins. The company is the culmination of more than 16 years of dedicated research to develop a process that can stimulate magnetism in several common natural elements and minerals.
Paramount Discoveries' technologies use an arbitrary wave form generator combined with permanent magnets, and apply a rare frequency for each element or mineral to sustain its "magnetic moment", thus controlling the element or mineral.
The 16 years of research has helped Paramount Discoveries to successfully generate these unique frequencies and overcome the overwhelming scientific odds of finding the correct frequency. Now, Paramount Discoveries continues to challenge the scientific community, researching and developing new technologies that prove the astronomical odds of discovering these frequencies are still possible.

Technology / Working on:



 

 

 

Itonis Pharmaceuticals Received Emesyl Samples for Evaluation

Feb 28, 2014

OTC Disclosure & News Service

-

Itonis Pharmaceuticals Received Emesyl Samples for Evaluation

LAGUNA HILLS, CA--(Marketwired - Feb 28, 2014) - Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl™ product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl™ anti-nausea formula which are currently being evaluating for tolerance.

"The two versions differ in terms of preservative," says Ernesto Barron, Itonis' recently appointed Chief Scientific Officer. "We are looking at using a class of preservative that will not only maintain product stability but also will serve to sooth the nasal passages."

About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a new division of Itonis, Inc., is headed by Charles Hensley, Ph.D. This division's mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

About Itonis, Inc.
Itonis, Inc. was incorporated in the state of Nevada on July 5, 2005 under the name of Kenshou, Inc., which later changed to Itonis, Inc. on December 2, 2005. Please visit www.itonisholdings.com.

Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact:
Itonis, Inc.

 

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals to Use Its Exclusive Manufacturer for Emesyl(TM) Anti-Nausea Swab and Oral Spray Products

LAGUNA HILLS, Calif., May 3, 2013 — Itonis, Inc. (ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company’s exclusive manufacturer (Oasis Health Products, Inc.) will produce the Company’s anti-nausea swab and its oral spray products under the Emesyl(TM) brand.

The Company expects to commence the production process with Oasis Health Products for Emesyl(TM) in both the swab and oral spray forms.

Dr. Hensley said, “We are excited that we are working with Oasis to produce the first of our Emesyl(TM) anti-nausea products. We look forward to making Emesyl(TM) available to the general public to treat nausea ailments.”

About Itonis Pharmaceuticals

Itonis Pharmaceuticals, a new division of Itonis, Inc., is headed by Charles Hensley, Ph.D. This division’s mission is to create and market over-the-counter and prescription homeopathic products that better people’s lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam(R) Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

 

 

PostSubject
#24459  Sticky Note READ THIS>>>>>>>>>>>>>>>>>>>> [SMART MONEY] 07/19/14 10:20:05 AM
#24009  Sticky Note Research story on zicam product launch and distribution. DoughRay 06/27/14 12:42:44 PM
#22188  Sticky Note "I'm a bit surprised that you haven't linked sunspotter 06/06/14 03:40:48 AM
#21764  Sticky Note WONDERFUL NEWS!!!!!! dcsteve 06/04/14 05:08:36 PM
#24731   You are right, what a useless board. People bashing Jar531 07/31/14 08:54:31 PM
#24730   What an useless board this has become. None DOLPHY 07/31/14 07:48:23 PM
#24729   People will say anything to get price down! ezyE 07/31/14 06:52:49 PM
#24728   It is a well known fact that the Semperfifi 07/31/14 06:22:16 PM
#24727   WHAT DOES THAT TELL YOU LONGS OR NEWBIES daytona52paul 07/31/14 04:43:04 PM
#24725   YOU WANT TO KNOW HOW I KNOW THAT daytona52paul 07/31/14 04:22:15 PM
#24724   FLORIDA HAS 80% APPROVAL OVERALL. MOST YOUNG daytona52paul 07/31/14 04:07:07 PM
#24723   CHILL OUT FOLKS, IT TAKES TIME TO DO envirogym 07/31/14 02:42:54 PM
#24722   Thanks tvset, I believe that the market is cycle4pennys 07/31/14 02:28:28 PM
#24721   I'm really excited about this company. As tvset 07/31/14 01:55:14 PM
#24720   I guess FDA is in on the scam ezyE 07/31/14 01:52:00 PM
#24717   It was exactly sept 12, 2013, that it tvset 07/31/14 01:40:01 PM
#24716   almost positive later today or tomorrow daytona52paul 07/31/14 01:01:44 PM
#24714   And that is the bitter pill of truth malc stone 07/31/14 12:38:10 PM
#24713   Profiteer, could you please educate the rest of vodkadejour 07/31/14 12:02:27 PM
#24711   "But we have no reason to believe anything sunspotter 07/31/14 11:34:34 AM
#24710   ITonis, Inc. (ITNS: OTC Pink Current) / Tier profiteer11 07/31/14 11:28:58 AM
#24709   Well now you're just being a little bit vodkadejour 07/31/14 10:30:12 AM
#24708   The relevance would be to keep your investors kpisme 07/31/14 09:27:28 AM
#24707   Fall of 13 meaning about 6-7 months ago?? YouOnlyLiveOnce 07/30/14 08:50:10 PM
#24706   Last PR 30 days ago...when there is relevant YouOnlyLiveOnce 07/30/14 08:47:20 PM
#24705   unless the company was afraid the person who tvset 07/30/14 07:27:39 PM
#24704   I agree with you. Those claiming this is stockcatman 07/30/14 06:55:57 PM
#24703   There was a post some weeks back where DOLPHY 07/30/14 06:39:09 PM
#24702   thanks for putting it in perspective. This tvset 07/30/14 06:02:43 PM
#24700   Well, now you have. I am very millionlafs 07/30/14 04:40:02 PM
#24699   stockcatman- This was not intended as a millionlafs 07/30/14 04:33:49 PM
#24698   I have yet to see anyone on this hebroots 07/30/14 04:29:31 PM
#24697   They have no track record on accountability, anything hebroots 07/30/14 04:27:34 PM
#24695   If you read everything about Emesyl and ITNS hebroots 07/30/14 04:22:52 PM
#24694   I would expect them to say that the hebroots 07/30/14 04:16:45 PM
#24693   I'm not concerned with the stock price. Not stockcatman 07/30/14 04:12:24 PM
#24691   It really doesn't matter what the pps is millionlafs 07/30/14 03:49:18 PM
#24690   They don't spear to be concerned with the stockcatman 07/30/14 03:24:40 PM
#24689   A-10 radecka 07/30/14 03:13:16 PM
#24688   A END 10 radecka 07/30/14 03:11:29 PM
#24687   Why did Itonis not tell us what the DOLPHY 07/30/14 03:08:02 PM
#24686   The time required to fill 16000 units is stockcatman 07/30/14 02:56:10 PM
#24685   This looks like a DUD!!!! pennystockpro32 07/30/14 02:50:43 PM
#24684   This product has been a long time in tvset 07/30/14 02:37:07 PM
#24683   It is amazing how long it is taking DOLPHY 07/30/14 02:12:38 PM
#24682   God only knows when the next news will kpisme 07/30/14 01:52:58 PM
#24681   C-8 millionlafs 07/30/14 01:14:34 PM
#24680   C AND 10 envirogym 07/30/14 12:49:05 PM
#24679   RIGHT ON, WE ARE ALL BIG BOYS! envirogym 07/30/14 12:47:03 PM
#24678   B-next 2 weeks with a 6 out of Moroski 07/30/14 12:33:44 PM
#24677   Keep up the good work... IMO... I still Gman24 07/30/14 12:26:43 PM
#24676   For my final post of the day, I'd vodkadejour 07/30/14 12:10:49 PM
#24669   ITNS steady for the day, and basically at vodkadejour 07/29/14 04:33:55 PM
#24668   Wow we couldn't even get a Lil EOD YouOnlyLiveOnce 07/29/14 04:17:05 PM
PostSubject